- Filed
- May 8, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · Mar 31, 2024 | 0 sh |
| Short Term Debt | Q1 2024 · Mar 31, 2024 | $95M |
| Short Term Debt | Q1 2024 · Dec 31, 2023 | $110M |
| Cash And Equivalents | Q1 2024 · Mar 31, 2024 | $190.83M |
| Cash And Equivalents | Q1 2024 · Dec 31, 2023 | $122.58M |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $789.82M |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $808.14M |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $5.24B |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $5.23B |
| Current Assets | Q1 2024 · Mar 31, 2024 | $1.07B |
| Current Assets | Q1 2024 · Dec 31, 2023 | $790.67M |
| Total Assets | Q1 2024 · Mar 31, 2024 | $8.06B |
| Total Assets | Q1 2024 · Dec 31, 2023 | $8.1B |
| Capex | Q1 2024 · Mar 31, 2023 | $60.1M |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | $112.44M |
| Net Income | Q1 2024 · Mar 31, 2023 | −$104.02M |
| Operating Income restated | Q1 2024 · Mar 31, 2023 | −$42.93M |
| Revenue | Q1 2024 · Mar 31, 2023 | $310.53M |